Cargando…
Biomarkers in the Management of Difficult Asthma
Difficult asthma is a heterogeneous disease of the airways including various types of bronchial inflammation and various degrees of airway remodeling. Therapeutic response of severe asthmatics can be predicted by the use of biomarkers of Type2-high or Type2-low inflammation. Based on sputum cell ana...
Autores principales: | Schleich, Florence, Sophie, Demarche, Renaud, Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997932/ https://www.ncbi.nlm.nih.gov/pubmed/26467509 http://dx.doi.org/10.2174/1568026616666151015093406 |
Ejemplares similares
-
A historical perspective: Are inhaled corticoids sufficient to control asthma?
por: Louis, Renaud, et al.
Publicado: (2015) -
Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?
por: Demarche, Sophie, et al.
Publicado: (2016) -
Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?
por: Demarche, Sophie F., et al.
Publicado: (2017) -
Granulocytic Airway Inflammation and Clinical Asthma Outcomes
por: Louis, Renaud E., et al.
Publicado: (2021) -
Are type-2 biomarkers of any help in asthma diagnosis?
por: Nekoee, Haleh, et al.
Publicado: (2020)